We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRSN
12026
CALL
DELISTED
Mersana Therapeutics
MRSN
$65.6K ﹤0.01%
1,836
+748
+69% +$38.7K
SCHR
12027
CALL
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$65.6K ﹤0.01%
2,700
+300
+13% +$7.38K
FINX icon
12028
PUT
Global X FinTech ETF
FINX
$170M
$65.6K ﹤0.01%
+2,100
New +$65.6K
CDMO
12029
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$65.5K ﹤0.01%
5,300
-22,000
-81% -$252K
SOLV icon
12030
Solventum
SOLV
$15.1B
$65.2K ﹤0.01%
+987
New +$69.1K
INFU icon
12031
CALL
InfuSystem Holdings
INFU
$244M
$65.1K ﹤0.01%
7,700
+5,800
+305% +$45.7K
PFLT icon
12032
PennantPark Floating Rate Capital
PFLT
$730M
$65K ﹤0.01%
5,947
-27,293
-82% -$306K
SPDW icon
12033
CALL
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42.1B
$64.8K ﹤0.01%
+1,900
New +$68K
SPDW icon
12034
PUT
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42.1B
$64.8K ﹤0.01%
+1,900
New +$68K
RPID icon
12035
Rapid Micro Biosystems
RPID
$84.3M
$64.8K ﹤0.01%
+72,024
New +$72.5K
REYN icon
12036
CALL
Reynolds Consumer Products
REYN
$5.53B
$64.8K ﹤0.01%
2,400
-4,000
-63% -$113K
EDIT icon
12037
CALL
Editas Medicine
EDIT
$433M
$64.8K ﹤0.01%
51,000
-7,000
-12% -$17.8K
OTLY
12038
PUT
Oatly Group
OTLY
$441M
$64.8K ﹤0.01%
4,885
-555
-10% -$8.18K
MFIC icon
12039
PUT
MidCap Financial Investment
MFIC
$803M
$64.8K ﹤0.01%
4,800
-7,000
-59% -$95K
ABEV icon
12040
PUT
Ambev
ABEV
$43.2B
$64.8K ﹤0.01%
35,000
+4,100
+13% +$9.07K
RPT
12041
CALL
Rithm Property Trust
RPT
$104M
$64.7K ﹤0.01%
3,633
-2,800
-44% -$51.6K
PYXS icon
12042
CALL
Pyxis Oncology
PYXS
$251M
$64.7K ﹤0.01%
41,500
+31,900
+332% +$92K
KG
12043
CALL
Kestrel Group
KG
$61.7M
$64.7K ﹤0.01%
1,915
+1,865
+3,730% +$59.6K
CWCO icon
12044
PUT
Consolidated Water Co
CWCO
$500M
$64.7K ﹤0.01%
2,500
-3,100
-55% -$78.9K
AMPX icon
12045
PUT
Amprius Technologies
AMPX
$1.83B
$64.7K ﹤0.01%
23,100
+16,000
+225% +$28K
BOOM icon
12046
PUT
DMC Global
BOOM
$155M
$64.7K ﹤0.01%
8,800
+1,400
+19% +$13.2K
CNS icon
12047
CALL
Cohen & Steers
CNS
$4.36B
$64.6K ﹤0.01%
700
+500
+250% +$49.5K
CPF icon
12048
Central Pacific Financial
CPF
$996M
$64.6K ﹤0.01%
2,224
-6,707
-75% -$200K
PHUN icon
12049
PUT
Phunware
PHUN
$42.8M
$64.6K ﹤0.01%
+12,420
New +$68.5K
WALD icon
12050
Waldencast
WALD
$173M
$64.6K ﹤0.01%
+16,065
New +$56.4K

Similar funds

Ken Griffin's Q4 2024 Portfolio in Review

As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
  • Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.